Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:23 pm Purchase |
2024-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
JANUS HENDERSON GROUP PLC JHG |
6,982,425 6.900% |
756,032 (+12.14%) |
Filing History |
| 2024-11-14 3:06 pm Purchase |
2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
JANUS HENDERSON GROUP PLC JHG |
6,226,393 6.600% |
325,050 (+5.51%) |
Filing History |
| 2024-11-12 1:20 pm Unchanged |
2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
The Vanguard Group | 7,785,909 8.230% |
0 (Unchanged) |
Filing History |
| 2024-11-04 11:16 am Purchase |
2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
The Vanguard Group | 7,785,909 8.230% |
7,785,909 (New Position) |
Filing History |
| 2024-02-14 07:00 am Sale |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
Point72 Asset Management, L.P. | 2,552,822 3.200% |
-1,508,521 (-37.14%) |
Filing History |
| 2024-02-13 5:08 pm Purchase |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,572,836 5.700% |
723,898 (+18.81%) |
Filing History |
| 2024-02-13 12:47 pm Purchase |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
JANUS HENDERSON GROUP PLC JHG |
5,901,343 7.400% |
1,338,832 (+29.34%) |
Filing History |
| 2024-02-06 09:36 am Purchase |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
BLACKROCK INC BLK |
5,762,738 7.200% |
1,606,592 (+38.66%) |
Filing |
| 2024-01-23 10:47 am Sale |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
STATE STREET CORP STT |
3,870,839 4.820% |
-720,223 (-15.69%) |
Filing History |
| 2023-10-18 4:15 pm Purchase |
2023-10-17 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
Point72 Asset Management, L.P. | 4,061,343 5.100% |
4,061,343 (New Position) |
Filing History |
| 2023-02-13 1:31 pm Purchase |
2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,848,938 5.700% |
8,600 (+0.22%) |
Filing History |
| 2023-02-13 12:49 pm Purchase |
2022-12-31 | 13G | Farmers & Merchants Bancorp, Inc. FMAO |
BLACKROCK INC BLK |
4,156,146 6.100% |
4,156,146 (New Position) |
Filing History |
| 2023-02-13 10:14 am Purchase |
2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
JANUS HENDERSON GROUP PLC JHG |
4,562,511 6.700% |
4,562,511 (New Position) |
Filing History |
| 2023-02-08 10:16 am Purchase |
2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
STATE STREET CORP STT |
4,591,062 6.740% |
4,591,062 (New Position) |
Filing History |
| 2022-11-02 09:35 am Purchase |
2022-10-21 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,840,338 5.600% |
3,840,338 (New Position) |
Filing History |